Laurion Capital Management LP Biomea Fusion, Inc. Transaction History
Laurion Capital Management LP
- $11.4 Billion
- Q1 2024
A detailed history of Laurion Capital Management LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 2,720,983 shares of BMEA stock, worth $12.2 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
2,720,983
Previous 2,736,367
0.56%
Holding current value
$12.2 Million
Previous $39.7 Million
2.38%
% of portfolio
0.36%
Previous 0.35%
Shares
6 transactions
Others Institutions Holding BMEA
# of Institutions
121Shares Held
25.7MCall Options Held
2.56MPut Options Held
879K-
State Street Corp Boston, MA4.49MShares$20.2 Million0.0% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$16.1 Million3.07% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$9.49 Million0.4% of portfolio
-
Black Rock Inc. New York, NY1.97MShares$8.88 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$6.15 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $132M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...